Glyceryl Monostearate Based Solid Lipid Nanoparticles for Controlled Delivery of Docetaxel

(E-pub Abstract Ahead of Print)

Author(s): Nadia Rai, Asadullah Madni*, Amir Faisal, Talha Jamshaid, Muhammad Imran Khan, Muhammad Muzamil Khan, Farzana Parveen

Journal Name: Current Drug Delivery

Become EABM
Become Reviewer
Call for Editor


Background: Solid Lipid Nanoparticles (SLNs) is the drug delivery systems that has the capability to improve drug release at the desired tumor site. The aim of present study was to develop Glyceryl Monostearate (GMS) based SLNs for the controlled delivery of docetaxel.

Method: Hot Melt Encapsulation (HME) method was employed avoiding the use of organic solvents and therefore, regarded as green synthesis of SLNs.

Results: Optimized DTX-SLNs showed desirable size (100 nm) with low poly dispersity index and excellent entrapment efficiency. Surface charge confirmed the stability of formulation. Transmission Electron Microscope (TEM) analysis showed spherical shaped particles and Fourier Transform Infrared Microscopy (FTIR) revealed compatibility among formulation excipients. Differential Scanning Calorimeter (DSC) analysis revealed that melting transition peak of optimized formulation was also greater than 40°C indicating that SLNs would be solid at body temperature. In-vitro release profile (68% in 24 hours) revealed the controlled release profile of DTX-SLNs indicating lipophilic docetaxel drug was entrapped inside high melting point lipid core. Cytotoxicity study revealed that blank SLNs were found to be biocompatible while dose dependent cytotoxicity was shown by DTX-SLNs.

Conclusion: These studies suggest that DTX-SLNs have potential for controlled delivery of docetaxel and improved therapeutic outcome.

Keywords: SLNs, GMS, docetaxel, hot melt encapsulation, breast cancer, controlled drug delivery, ovarian cancer.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Abstract Ahead of Print)
DOI: 10.2174/1567201818666210203180153
Price: $95